首页> 外文会议>Society for Biomaterials annual meeting and exposition >Redirection of human HER2-positive breast cancer cells
【24h】

Redirection of human HER2-positive breast cancer cells

机译:人HER2阳性乳腺癌细胞的重定向

获取原文

摘要

In this work, redirection was achieved by using three HER2~+ mammary tumor cell lines in vitro. It was demonstrated by attenuation of HER2 phosphorylation in vitro and reduction of sphere formation. Formation of mammospheres has correlated to stem cell function and tumor-initiation capacity. The HER2~+ breast cancer cell lines formed significantly higher numbers of spheres compared to the non-tumorigenic breast epithelial MCF10A cell line. Mammosphere formation is decreased in redirected cancer cells Breast cancer stem cells are HER2~+ regardless of pathological or genetic classification. This proves that HER2 expression is not only a target in HER2~+ breast cancer but should be targeted in all breast cancers to prevent breast cancer stem cells from recapitulating tumors following treatment. Our data demonstrates that by attenuating activity of HER2 theses cancer cells lose the capacity to form tumors in vivo and lose their cancer phenotype in vitro.
机译:在这项工作中,通过在体外使用三种HER2〜+乳腺肿瘤细胞系实现了重定向。通过体外HER2磷酸化的减弱和球形成的减少证明了这一点。乳球的形成与干细胞功能和肿瘤起始能力有关。与非致瘤性乳腺癌上皮MCF10A细胞系相比,HER2 +乳腺癌细胞系形成的球体数量明显增加。重定向的癌细胞中乳腺球的形成减少乳腺癌干细胞是HER2 +,而与病理学或遗传学分类无关。这证明HER2表达不仅是HER2 +乳腺癌的靶标,而且在所有乳腺癌中均应靶向以防止乳腺癌干细胞在治疗后重现肿瘤。我们的数据表明,通过减弱HER2的活性,这些癌细胞丧失了在体内形成肿瘤的能力,而在体外丧失了其癌症表型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号